Michael McElhaugh
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael McElhaugh
Michael McElhaugh is recorded as CEO and COO at Arbutus Biopharma Corp (ABUS). The proxy statement of Arbutus Biopharma Corp reports total compensation of $3,578,150 for Michael McElhaugh in fiscal 2025, including a base salary of $109,658. Disclosed compensation is on record for 6 fiscal years. Michael McElhaugh has spoken on 1 earnings call across 1 company, most recently for Arbutus Biopharma Corp on August 1, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Arbutus Biopharma Corp (ABUS)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arbutus Biopharma Corp
Other people whose current roles at this company are on record from its filings.
- Lindsay Androski CEO, Chairman, Board Member
- Mark J. Murray CEO
- Michael J. McElhaugh CEO, COO, Board Member
- Tuan Nguyen CFO
- Mike McElhaugh COO
- J. Christopher Naftzger General Counsel
- Anuj Hasija Board Member
- Eric Venker, M.D., Pharm.D. Board Member
- Frank Torti, M.D. Board Member
- Joseph Bishop Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arbutus Biopharma Corp (ABUS) | Former Interim President and Chief Executive Officer | $109,658 | $3,578,150 |
| 2024 | Arbutus Biopharma Corp (ABUS) | Former Interim President and Chief Executive Officer | $642,500 | $2,110,083 |
| 2023 | Arbutus Biopharma Corp (ABUS) | Former Interim President and Chief Executive Officer | $483,000 | $1,620,485 |
| 2022 | Arbutus Biopharma Corp (ABUS) | Current Interim President and Chief Executive Officer | $448,750 | $1,315,235 |
| 2021 | Arbutus Biopharma Corp (ABUS) | COO | — | — |
| 2020 | Arbutus Biopharma Corp (ABUS) | — | $415,000 | $1,087,791 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.